IW 390

August 9, 2026 Viktor Zarev 0 min read
  1. FDA approves first mRNA flu vaccine.
  2. Senate committee votes to hold Fauci in contempt.
  3. Lab-leak proponent in line to take Fauci’s previous job.
  4. What China knows about COVID-19’s origins.
  5. Michigan nurses track down origins of cyclosporiasis cases.
  6. FDA approves twice-rejected melanoma drug. 
  7. Merger of pharma giants seen as “unlikely.” 
  8. Philips forms partnerships around wearable devices.
  9. Fight erupts in Washington, DC, over opioid settlement money. 
  10. GLP-1 users are spending less on groceries.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiogenetics September 10, 2026

Can Polygenic Risk Scores Uncover Hidden CVD? September 10, 2026

It’s rare that one gene causes CVD, just as it’s rare for one CV condition to occur in isolation. In a recent JACC issue, researchers show that […]

Cardiology Pharmaceuticals September 10, 2026

Novo, Novartis, and How Two Trials Cast Doubt on CVD Biomarkers September 10, 2026

Cardiology just took back-to-back blows to two of its most promising prevention strategies. One drug for lowering lipoprotein(a) and another targeting interleukin-6 both failed in major trials, even as fresh data reaffirms just how much those factors matter.

Surgeries & Interventions September 3, 2026

A Tale of Two Studies and the Importance of Patient Selection September 3, 2026

Two recent studies are forcing an important conversation in cardiology – some of the field's most common procedures may not be as clearly beneficial as open-label data originally suggests.